Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker-Reference-Cited by-同舟云学术

Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker

Published:2014-07 Issue:4 Volume:16 Page:467-476
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Giachelia Manuela,Bozzoli Valentina,D'Alò Francesco,Tisi Maria Chiara,Massini Giuseppina,Maiolo Elena,Guidi Francesco,Cupelli Elisa,Martini Maurizio,Larocca Luigi M.,Voso Maria Teresa,Leone Giuseppe,Hohaus Stefan

Funder

Italian Association of Cancer Research

Sacred Heart Catholic University of Rome

Nadia Salcini Foundation

Associazione per il progresso della terapia intensiva onocematologica

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference41 articles.

1. Follicular lymphoma international prognostic index;Solal-Céligny;Blood,2004

2. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project;Federico;J Clin Oncol,2009

3. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival;O'Shea;Blood,2008

4. High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature;Herold;Leuk Lymphoma,2013

5. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma;Krajnović;Med Oncol,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on epigenetics of small B-cell lymphoma;Clinical and Translational Oncology;2022-03-25

2. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells;Oncology Reports;2021-11-08

3. Calcium-dependent signalling in B-cell lymphomas;Oncogene;2021-10-08

4. High temperature requirement A1 in cancer: biomarker and therapeutic target;Cancer Cell International;2021-09-25

5. Diagnosis and treatment of lymphomas in the era of epigenetics;Blood Reviews;2021-07